CLASS II ONGOING Drug recall · Reported 22 Apr 2026 · FDA Enforcement Report
Blemish Spot Treatment (Salicylic Acid) 1%, ., Skin Script recalled
Island Kinetics, Inc. d.b.a. CoValence Laboratories is recalling Blemish Spot Treatment (Salicylic Acid) 1%, ., Skin Script, Chandler, AZ 85226, distributed nationwide in the US. The recall was initiated on 1 Apr 2026 and the FDA has classified it as Class II.
Check your package
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
Recall details
- Recall number
- D-0487-2026
- FDA event ID
- 98705
- Recalling firm
- Island Kinetics, Inc. d.b.a. CoValence Laboratories, Chandler, AZ
- Classification
- Class II
- Status
- Ongoing
- Recall initiated
- 1 Apr 2026
- FDA classified
- 22 Apr 2026
- Reported
- 22 Apr 2026
- Type
- Voluntary: Firm initiated
- Customers notified by
- Letter
- Reason category
- Potency & Assay
Timeline
| 1 Apr 2026 | Recall initiated by company | |
| 22 Apr 2026 | Classified by FDA | +21 days |
| 22 Apr 2026 | Published in enforcement report | +0 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
Failed Stability Specifications
Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.
Product as listed by the FDA
Blemish Spot Treatment (Salicylic Acid) 1%, .5 fl oz (15 ml) bottles, Skin Script, Chandler, AZ 85226, UPC 6 10563 13873 9.
Where it was distributed
U.S. Nationwide
Questions about this recall
Why was it recalled?
Failed Stability Specifications
Which lots are affected?
Lot#: 4228D2, 4229D1, Exp.: 07/31/2026 Lot#: 5147D2, Exp.: 04/30/2027
Where was it sold?
U.S. Nationwide
What should I do if I have it?
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
What does Class II mean?
Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.
Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.